Loading institutional data...
Loading institutional data...
Held by 251 of 5,944 reporting institutions (93th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 6%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $306M covers the $183M due within a year 1.7× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-08-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
7/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $40M dividends + $23M buybacks = $62M returned on -$15M FCF.
3 consecutive years of dividend increases · 5%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 83.8 | 87.9 | 87.4 | 86.7 | 89.7 | 88.8 | 84.2 | 81.3 |
| Gross Profit | 16.2 | 12.1 | 12.6 | 13.3 | 10.3 | 11.2 | 15.8 | 18.7 |
| R&D | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.1 | 0.1 | 0.2 |
| SG&A | 8.0 | 7.0 | 7.3 | 11.0 | 7.6 | 6.0 | 7.0 | 8.1 |
| Operating Income | 10.0 | 6.1 | 6.0 | 2.3 | 4.0 | 4.5 | 9.2 | 11.1 |
| Income Tax | 1.3 | 1.4 | 1.4 | -2.3 | 0.6 | 0.6 | 1.7 | 2.8 |
| Net Income | 6.0 | 2.3 | 1.8 | 1.9 | 1.6 | 1.6 | 4.5 | 6.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on GBX: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.24B 100.0% | $3.54B 100.0% | $3.94B 100.0% | $2.98B 100.0% | $1.75B 100.0% | $2.79B 100.0% | $3.03B 100.0% | $2.52B 100.0% | $2.17B 100.0% | $2.68B 100.0% |
| Cost of Revenue | $2.63B 81.3% | $2.99B 84.2% | $3.50B 88.8% | $2.67B 89.7% | $1.52B 86.7% | $2.44B 87.4% | $2.67B 87.9% | $2.11B 83.8% | $1.75B 80.6% | $2.13B 79.4% |
| Gross Profit | $607.5M 18.7% | $558.5M 15.8% | $441.1M 11.2% | $306.0M 10.3% | $231.6M 13.3% | $353.1M 12.6% | $366.5M 12.1% | $409.1M 16.2% | $421.3M 19.4% | $551.4M 20.6% |
| Research & Development | $5.5M 0.2% | $5.2M 0.1% | $4.0M 0.1% | $5.4M 0.2% | $6.3M 0.4% | $5.8M 0.2% | $5.4M 0.2% | $6.0M 0.2% | $4.2M 0.2% | $2.7M 0.1% |
| Selling, General & Admin | $263.3M 8.1% | $247.1M 7.0% | $235.3M 6.0% | $225.2M 7.6% | $191.8M 11.0% | $204.7M 7.3% | $213.3M 7.0% | $200.4M 8.0% | $170.6M 7.9% | $158.7M 5.9% |
| Operating Income | $360.1M 11.1% | $324.5M 9.2% | $176.4M 4.5% | $118.0M 4.0% | $41.0M 2.3% | $168.4M 6.0% | $184.1M 6.1% | $253.0M 10.0% | $260.4M 12.0% | $408.6M 15.2% |
| Pretax Income | $284.4M 8.8% | $223.7M 6.3% | $91.0M 2.3% | $60.6M 2.0% | -$8.6M -0.5% | $124.8M 4.5% | $153.2M 5.1% | $223.6M 8.9% | $236.2M 10.9% | $395.1M 14.7% |
| Income Tax Expense | $91.4M 2.8% | $62.0M 1.7% | $24.6M 0.6% | $18.1M 0.6% | -$40.2M -2.3% | $40.2M 1.4% | $41.6M 1.4% | $32.9M 1.3% | $64.0M 3.0% | $112.3M 4.2% |
| Net Income | $204.1M 6.3% | $160.1M 4.5% | $62.5M 1.6% | $46.9M 1.6% | $32.4M 1.9% | $49.0M 1.8% | $71.1M 2.3% | $151.8M 6.0% | $116.1M 5.4% | $183.2M 6.8% |
| Per Share | ||||||||||
| EPS (Basic) | $6.55 | $5.15 | $1.95 | $1.44 | $0.99 | $1.50 | $2.18 | $4.92 | $3.97 | $6.28 |
| EPS (Diluted) | $6.35 | $4.96 | $1.89 | $1.40 | $0.96 | $1.46 | $2.14 | $4.68 | $3.65 | $5.73 |
| Weighted Avg Shares (Basic) | 31.2M | 31.1M | 32.0M | 32.6M | 32.6M | 32.7M | 32.6M | 30.9M | 29.2M | 29.2M |
| Weighted Avg Shares (Diluted) | 32.1M | 32.4M | 33.8M | 33.6M | 33.7M | 33.4M | 33.2M | 32.8M | 32.6M | 32.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $166.7B | 23.4× | 16.0× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.0B | 32.5× | 23.2× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| VRT | $91.6B | 70.2× | 43.4× | 8.9× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.2B | 31.9× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $83.9B | 15.1× | 9.4× | 0.9× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| GBX | $1.3B | 6.7× | 5.7× | 0.4× | -8.6% | 18.7% | 6.3% | 13.3% | 6.2% | 3.6× | 251 |
Peers = companies sharing GBX's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.